Evidence map›Paper›PMID 41175269›Full record

ArticleMikrochimica acta2025

Amorphous-to-crystalline transition strategy boosting copper-nickel bimetallic anchored hollow covalent organic framework nanozyme for colorimetric sensing of epinephrine.

Ran Na, Yuying Yuan, Ziyi Yang, Jianliang Chen, Yixi Gu, Ting Bao, Xiuhua Zhang, Shengfu Wang, Wei Wen

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ran NaMinistry of Education Key Laboratory for the Synthesis and Application of Organic Functional Molecules, Hubei Key Laboratory for Precision Synthesis of Small Molecule Pharmaceuticals, College of Chemistry and Chemical Engineering, Hubei University, Wuhan, 430000, China.
Yuying YuanMinistry of Education Key Laboratory for the Synthesis and Application of Organic Functional Molecules, Hubei Key Laboratory for Precision Synthesis of Small Molecule Pharmaceuticals, College of Chemistry and Chemical Engineering, Hubei University, Wuhan, 430000, China.
Ziyi YangMinistry of Education Key Laboratory for the Synthesis and Application of Organic Functional Molecules, Hubei Key Laboratory for Precision Synthesis of Small Molecule Pharmaceuticals, College of Chemistry and Chemical Engineering, Hubei University, Wuhan, 430000, China.
Jianliang ChenMinistry of Education Key Laboratory for the Synthesis and Application of Organic Functional Molecules, Hubei Key Laboratory for Precision Synthesis of Small Molecule Pharmaceuticals, College of Chemistry and Chemical Engineering, Hubei University, Wuhan, 430000, China.
Yixi GuAnalysis and Testing Center, Wuhan Institute of Technology, No. 206 Guanggu 1st Road, Wuhan, 430000, China. guyixi@wit.edu.cn.
Ting BaoMinistry of Education Key Laboratory for the Synthesis and Application of Organic Functional Molecules, Hubei Key Laboratory for Precision Synthesis of Small Molecule Pharmaceuticals, College of Chemistry and Chemical Engineering, Hubei University, Wuhan, 430000, China. baoting@hubu.edu.cn.
Xiuhua ZhangMinistry of Education Key Laboratory for the Synthesis and Application of Organic Functional Molecules, Hubei Key Laboratory for Precision Synthesis of Small Molecule Pharmaceuticals, College of Chemistry and Chemical Engineering, Hubei University, Wuhan, 430000, China.
Shengfu WangMinistry of Education Key Laboratory for the Synthesis and Application of Organic Functional Molecules, Hubei Key Laboratory for Precision Synthesis of Small Molecule Pharmaceuticals, College of Chemistry and Chemical Engineering, Hubei University, Wuhan, 430000, China.
Wei WenMinistry of Education Key Laboratory for the Synthesis and Application of Organic Functional Molecules, Hubei Key Laboratory for Precision Synthesis of Small Molecule Pharmaceuticals, College of Chemistry and Chemical Engineering, Hubei University, Wuhan, 430000, China. wenwei@hubu.edu.cn.

Funding

National Natural Science Foundation of China 22376055, 22076041Open Funding Project of the Hubei Key Laboratory for Precision Synthesis of Small Molecule Pharmaceuticals HKLB2415State Key Laboratory of Analytical Chemistry for Life Science SKLACLS2521
6 · The paper itself

Abstract

Hollow covalent organic framework (HCOF) with a well-ordered pore structure can provide a robust platform for the anchoring of metal nanoparticles to design an innovative and potent nanozyme. Herein, an amorphous-to-crystalline transition strategy was utilized to synthesize the uniform HCOF, which was used as an effective nanocarrier for the anchoring of Cu-Ni bimetallic nanoparticles to prepare Cu-Ni/HCOF nanozyme with laccase-mimicking activity. By integrating the morphological control of amorphous covalent organic polymer (COP) and the crystallization-induced hollowing out, the synthesized HCOF increased the substrate enrichment and diffusion, super-adding the massive loading of Cu-Ni nanoparticles, which significantly promoted the catalytic activity. Taking advantage of the laccase-mimicking activity of the Cu-Ni/HCOF nanozyme, simple and efficient detection of epinephrine was achieved with a detection limit of 0.14 µg/mL. This colorimetric sensing strategy offered an efficient approach for epinephrine detection in a complex matrix, exhibiting potential application in the early diagnosis of disease.

Indexed as

ColorimetryCopperEpinephrineMetal NanoparticlesMetal-Organic FrameworksNickelCatalysisLaccaseLimit of DetectionCopperEpinephrineLaccaseMetal-Organic FrameworksNickelAmorphous-to-crystalline transition strategyColorimetric sensing platformCu-Ni/HCOF nanozymeEpinephrineLaccase-mimicking activity

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.